# Lutein Skin Health Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/lutein-skin-health-randomized-trial-evidence-review
Category: evidence-review
Summary: Lutein Skin Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are ran
Last reviewed: 2026-07-06
Reviewed by: Migaku Evidence Review
# Lutein Skin Health Randomized Trial: What the Evidence Says

## Quick Answer

Lutein Skin Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Carotenoid Status and Psychological Impact of Presymptomatic Macular Degeneration Genetic Risk Assessment: The MAGENTA Randomized Trial | randomized trial | 2 | 2026-04-01 | 10.1016/j.xops.2026.101083 |
| Effect of carotenoids supplementation on visual function in Chinese adults free of retinal disease: protocol for the CSV double-blind, randomised, placebo-controlled trial | randomized trial | 2 | 2026-01-01 | 10.1136/bmjopen-2025-112364 |

## What The Sources Report

- Therefore, we conducted this trial to investigate whether knowledge of AMD genetic risk will inform the adoption of a healthier lifestyle that could reduce the incidence of AMD later in life. [Addo Emmanuel K. (2026); evidence level 2]
- Additionally, we explored the psychological impact of AMD genetic risk disclosure on individuals' well-being. [Addo Emmanuel K. (2026); evidence level 2]
- It aims to provide high-quality evidence on the impact of dietary carotenoid supplementation on visual function in the normal Chinese population, supporting nutritionists and physicians in improving visual function through dietary interventions and paving the way for future large-scale clinical studies. [Xu Kan (2026); evidence level 2]
- These carotenoids are specifically concentrated in the macula lutea via high-affinity binding proteins and specialised transport and metabolic proteins.However, humans are unable to synthesise carotenoids such as L and Z. [Xu Kan (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For lutein skin health randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Addo Emmanuel K. (2026). Carotenoid Status and Psychological Impact of Presymptomatic Macular Degeneration Genetic Risk Assessment: The MAGENTA Randomized Trial. DOI: 10.1016/j.xops.2026.101083. PMCID: PMC12964007. PMID: 41799797. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12964007/
- Xu Kan (2026). Effect of carotenoids supplementation on visual function in Chinese adults free of retinal disease: protocol for the CSV double-blind, randomised, placebo-controlled trial. DOI: 10.1136/bmjopen-2025-112364. PMCID: PMC13034290. PMID: 41887628. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13034290/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.